Clinical Trials Logo

Clinical Trial Summary

This study is to compare the maternal and neonatal outcomes in the patients with PPROM who are managed at home versus those managed at hospital, half the patients will be managed at home and the other half will be managed inpatient.


Clinical Trial Description

Now the current practice is to manage patients with PPROM at hospital, however it is not known yet whether this practice is better than outpatient management as regard maternal and neonatal outcome.

There is some recent evidence that home management of PPROM is safe for both mother and neonate, home management is also more convenient with less expenses. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT02548013
Study type Interventional
Source Ain Shams Maternity Hospital
Contact Dina M Ibrahim
Phone 00201223603223
Email Dr_dinamostafa@hotmail.com
Status Recruiting
Phase N/A
Start date August 2014
Completion date July 2016

See also
  Status Clinical Trial Phase
Completed NCT01431248 - PPROM Erythromycin Versus Azithromycin N/A
Active, not recruiting NCT04588220 - Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM
Completed NCT02314728 - Cervical Ripening in Premature Rupture of Membranes N/A
Not yet recruiting NCT01152528 - Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion And Preterm Delivery In Pregnant Women With Previous Preterm Delivery Phase 3
Completed NCT02702297 - Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes
Not yet recruiting NCT02635451 - The Relation Between Serum Ascorbic Acid Concentration and Preterm Premature Rupture of Membranes N/A
Completed NCT01266928 - Does Vitamins C and E Supplementation of After Preterm Rupture of Membranes Prolong the Duration of Latency? A Prospective Randomized Controlled Study Phase 3
Active, not recruiting NCT04532021 - Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM
Recruiting NCT01584323 - Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes N/A
Recruiting NCT00466128 - Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) Phase 2
Terminated NCT00463736 - Magnesium Sulfate Versus Placebo for Tocolysis in PPROM N/A